DK38984D0 - Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker pa centralnervesystemet, fremgangsmade til fremstilling heraf og laegemidler med indhold heraf - Google Patents

Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker pa centralnervesystemet, fremgangsmade til fremstilling heraf og laegemidler med indhold heraf

Info

Publication number
DK38984D0
DK38984D0 DK0389/84A DK38984A DK38984D0 DK 38984 D0 DK38984 D0 DK 38984D0 DK 0389/84 A DK0389/84 A DK 0389/84A DK 38984 A DK38984 A DK 38984A DK 38984 D0 DK38984 D0 DK 38984D0
Authority
DK
Denmark
Prior art keywords
procedures
amino
impact
manufacturing
nervous system
Prior art date
Application number
DK0389/84A
Other languages
English (en)
Other versions
DK38984A (da
DK162985C (da
DK162985B (da
Inventor
Jean-Pierre Chambon
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK38984D0 publication Critical patent/DK38984D0/da
Publication of DK38984A publication Critical patent/DK38984A/da
Publication of DK162985B publication Critical patent/DK162985B/da
Application granted granted Critical
Publication of DK162985C publication Critical patent/DK162985C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK038984A 1983-01-27 1984-01-27 Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf DK162985C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central
FR8301234 1983-01-27

Publications (4)

Publication Number Publication Date
DK38984D0 true DK38984D0 (da) 1984-01-27
DK38984A DK38984A (da) 1984-07-28
DK162985B DK162985B (da) 1992-01-06
DK162985C DK162985C (da) 1992-06-01

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
DK038984A DK162985C (da) 1983-01-27 1984-01-27 Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker paa centralnervesystemet, fremgangsmaade til fremstilling heraf og laegemidler med indhold heraf

Country Status (27)

Country Link
US (1) US4721711A (da)
EP (1) EP0117779B1 (da)
JP (1) JPS59141564A (da)
KR (1) KR910000638B1 (da)
AR (1) AR240045A1 (da)
AT (1) ATE48417T1 (da)
AU (2) AU2372984A (da)
CA (1) CA1238637A (da)
DD (1) DD220026A5 (da)
DE (1) DE3480653D1 (da)
DK (1) DK162985C (da)
ES (1) ES529081A0 (da)
FI (1) FI78691C (da)
FR (1) FR2540113A1 (da)
HU (1) HU193890B (da)
IE (1) IE57054B1 (da)
IL (1) IL70756A (da)
MA (1) MA20018A1 (da)
NO (1) NO840313L (da)
NZ (1) NZ206945A (da)
OA (1) OA07644A (da)
PH (1) PH21162A (da)
PL (1) PL142340B1 (da)
PT (1) PT77993B (da)
SG (1) SG93690G (da)
YU (1) YU14284A (da)
ZA (1) ZA84502B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
JP2008518955A (ja) * 2004-11-02 2008-06-05 ノースウェスタン ユニバーシティ ピリダジン化合物および方法
EP2592075B1 (en) * 2004-11-02 2015-04-29 Northwestern University Pyridazine compounds for the treatment of inflammatory diseases
US20100168120A1 (en) * 2006-04-28 2010-07-01 Neuromedix Inc. Salts of pyridazine compounds
EP2063894B1 (en) * 2006-04-28 2019-08-28 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
WO2007127474A2 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2142498A2 (en) * 2007-04-02 2010-01-13 Institute for Oneworld Health Cftr inhibitor compounds and uses thereof
WO2009131951A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
EP2341776A4 (en) * 2008-09-19 2012-05-30 Inst Oneworld Health COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING IMIDAZOL AND TRIAZOL DERIVATIVES
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
FI78691C (fi) 1989-09-11
EP0117779A1 (fr) 1984-09-05
FR2540113A1 (fr) 1984-08-03
AU2372984A (en) 1984-08-02
PT77993A (fr) 1984-02-01
CA1238637A (en) 1988-06-28
PH21162A (en) 1987-08-05
NZ206945A (en) 1987-07-31
KR840007586A (ko) 1984-12-08
KR910000638B1 (ko) 1991-01-31
FI78691B (fi) 1989-05-31
DE3480653D1 (de) 1990-01-11
ES8500243A1 (es) 1984-10-01
AR240045A1 (es) 1990-01-31
IE840149L (en) 1984-07-27
PL142340B1 (en) 1987-10-31
SG93690G (en) 1991-01-18
AU2142188A (en) 1989-03-16
ATE48417T1 (de) 1989-12-15
DK38984A (da) 1984-07-28
EP0117779B1 (fr) 1989-12-06
IL70756A (en) 1987-03-31
PT77993B (fr) 1986-04-10
OA07644A (fr) 1985-05-23
FI840323A (fi) 1984-07-28
US4721711A (en) 1988-01-26
YU14284A (en) 1986-12-31
ZA84502B (en) 1984-09-26
ES529081A0 (es) 1984-10-01
DD220026A5 (de) 1985-03-20
NO840313L (no) 1984-07-30
DK162985C (da) 1992-06-01
PL245931A1 (en) 1985-07-16
FR2540113B1 (da) 1985-05-17
IE57054B1 (en) 1992-04-08
JPS59141564A (ja) 1984-08-14
IL70756A0 (en) 1984-04-30
MA20018A1 (fr) 1984-10-01
DK162985B (da) 1992-01-06
AU652118B2 (en) 1994-08-18
FI840323A0 (fi) 1984-01-26
HU193890B (en) 1987-12-28

Similar Documents

Publication Publication Date Title
DK38984D0 (da) Pyridazinderivater, som i 3-stillingen er substitueret med amino, og som indvirker pa centralnervesystemet, fremgangsmade til fremstilling heraf og laegemidler med indhold heraf
DK163988C (da) 9alfa,11alfa-epoxy-20-spiroxaner og analoge deraf med aaben tetrahydrofuranring e samt deres fremstilling og farmaceutiske praeparater indeholdende dem
EP0201741A3 (en) Dipeptide derivatives, processes for preparing them, pharmaceutical composition and use
AU7895687A (en) Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
PH21029A (en) Benzene derivatives, pharmaceutical compositions and method of use thereof
EP0211363A3 (en) 3-phenylthiomethylstyrene derivative, process for preparing the same, and antiallergic agent and tyrosinekinase inhibiting agent containing the same
DK43685D0 (da) Benzobicycliske lactamsyrer og derivater deraf, fremgangsmaade til deres fremstilling samt deres anvendelse
DK212784A (da) Ergolinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler med indhold heraf
DK418684A (da) Farmaceutiske midler indeholdende pyridazinonderivater, fremgangsmaade til fremstilling heraf samt mellemprodukter derfor
EP0144853A3 (en) Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
DK165985C (da) 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
DK361288D0 (da) Hydroxyethylazolylderivater, deres fremstilling og anvendelse samt mellemprodukter til fremstilling og disses fremstilling
DK136784D0 (da) Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf
DK617684A (da) 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
DK442183A (da) Thiatriazin-derivater, fremgangsmaader til fremstilling deraf og deres anvendelse som laegemidler
DK136684D0 (da) Pyrazolo(1,5-a)pyridinderivater samt fremgangsmaade til fremstilling deraf
DK260884D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-en-derivater,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
EP0172919A4 (en) CEPHALOSPORINE COMBS, THEIR PRODUCTION PROCESS AND THEIR USE AS MEDICINAL PRODUCTS.
DK492289A (da) 3-aryloxymethyl-cephalosporinderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende derivaterne
DK624288A (da) 3-substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK367887D0 (da) Arylethanolhydroxylaminer, deres fremstilling og anvendelse samt mellemprodukter til fremstilling ogdisses fremstilling
DK166273C (da) Dialkanoyloxybenzyliden-dialkanoat, fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende dette
NO843158L (no) 1,6-nafthydrinderivater og fremgangsmaate for deres fresmtilling